US EditionAvicanna Announces Sponsorship of Pilot Phase II Clinical Study Osteoarthritis Pain
Summary by Northumberland News
3 Articles
3 Articles
All
Left
2
Center
Right
1
NiagaraFallsReview.ca+2 Reposted by 2 other sources
Avicanna Announces Sponsorship of Pilot Phase II Clinical Study Osteoarthritis Pain
TORONTO, May 20, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is pleased to announce it has entered into…
·Niagara Falls, Canada
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left2Leaning Right1Center0Last UpdatedBias Distribution67% Left
Bias Distribution
- 67% of the sources lean Left
67% Left
L 67%
R 33%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
